E9-14907. The Essentials of Medical Device Regulations: A Primer for Manufacturers and Importers; Public Seminar  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice of public seminar.

    SUMMARY:

    The Food and Drug Administration's (FDA's) Center for Devices and Radiological Health and Office of Regulatory Affairs, in cooperation with AdvaMed's Medical Technology Learning Institute, is announcing a series of three public seminars on FDA medical device regulations.

    These 2-day public seminars, which are designed to address the training needs of startup and small device manufacturers and their suppliers, will include both industry and FDA perspectives and a question and answer period.

    DATES:

    For the dates of the public seminars, see table 1 in the SUPPLEMENTARY INFORMATION section of this document.

    ADDRESSES:

    For the locations of the public seminars, see table 1 in the SUPPLEMENTARY INFORMATION section of this document.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    For FDA:

    William Sutton, Division of Small Manufacturers, International and Consumer Assistance, Center for Devices and Radiological Health, 10903 New Hampshire Ave., W066-4626, Silver Spring, MD 20993-0002, 301-796-5849, FAX: 301-847-8149, e-mail: William.Sutton@fda.hhs.gov.

    For AdvaMed:

    For hotel and general information: Veronica Allen, 202-434-7231, vallen@advamed.org.

    For registration information: Katia Kunze, 202-434-7237, FAX: 202-783-8750, kkunze@advamed.org

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    I. Background

    The “Essentials of Medical Device Regulations: A Primer for Manufacturers and Importers” seminar helps fulfill the Department of Health and Human Services' and FDA's important mission to protect the public health by educating new entrepreneurs on the essentials of FDA device regulations. FDA has made education of the medical device community a high priority to assure the quality of products reaching the marketplace and to increase the rate of voluntary industry compliance with regulations.

    The seminar helps to implement the objectives of section 903 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 393) and the FDA Plan for Statutory Compliance, which includes working more closely with stakeholders and ensuring access to needed scientific and technical expertise.

    The seminar also furthers the goals of the Small Business Regulatory Enforcement Fairness Act (Public Law 104-121) by providing outreach activities by Government agencies directed at small businesses.

    The following topics, as well as others, will be discussed at the seminar:

    • Doing business in a regulated industry;
    • Organizational structure of FDA;
    • Overview of the quality system regulation;
    • Design controls;
    • Documents, records, and change control;
    • Purchasing controls and acceptance activities;
    • Production and process control;
    • Corrective and preventive actions;
    • Complaints, medical device reports, corrections, and recalls;
    • Compliance issues;
    • Management responsibility;
    • Interacting with FDA—Where do you go for assistance?
    • General question and answer session;
    • Manufacturers and suppliers—The chain regulatory responsibility;
    • Reimbursement of medical technology;
    • The AdvaMed code of ethics; and
    • Fraud and abuse.

    II. Public Seminar Locations and Dates

    The locations and dates for the public seminars are listed in table 1 of this document.Start Printed Page 30100

    Table 1.—Seminar Locations and Dates

    Seminar LocationDate
    Coronado Island Marriott Resort and Spa, 2000 Second St., Coronado, CA 92118. Details are posted on AdvaMed's Web site at www.advamedmtli.org/​san_​diego1July 14 and 15, 2009
    Gaylord Opryland Resort, 2802 Opryland Dr., Nashville, TN 37214. Details are posted on AdvaMed's Web site at www.advamedmtli.org/​nashville1August 4 and 5, 2009
    San Juan Marriott Resort and Stellaris Casino, 1309 Ashford Ave., San Juan, PR 00907. Details are posted on AdvaMed's Web site at www.advamedmtli.org/​puerto_​rico1August 12 and 13, 2009
    1 FDA has verified the Web site addresses, but FDA is not responsible for any subsequent changes to the Web sites after this document publishes in the Federal Register.

    III. Registration

    The registration fee is $650 per person per seminar. The registration fee will be used to offset the expenses of hosting the conference, including meals (breakfasts and a lunch), refreshments, meeting rooms, and training materials. It also includes a networking reception on the evening of the first day of each seminar.

    To register and pay by personal check: Send your registration information (including name, title, firm name, address, telephone, and fax number) to Katia Kunze, AdvaMed, 202-434-7237, FAX: 202-783-8750, or email kkunze@advamed.org. Katia Kunze will then provide you with information on how to pay your registration fee by check.

    To register and pay via the Internet: Visit the designated Web site for the seminar that you plan to attend (see table 1 of this document). Payment forms accepted are major credit card (MasterCard, Visa, or American Express).

    Space is limited; therefore, interested parties are encouraged to register early. If you need special accommodations due to a disability, please contact Veronica Allen (see For Further Information Contact) at AdvaMed at least 7 days in advance of the seminar.

    Attendees are responsible for their own accommodations. For hotel information and meeting locations, see table 1 of this document. There are a limited number of hotel rooms blocked for the seminars. Please be advised that the seminar room blocks close 1 month before the beginning of the seminar. Interested parties are encouraged to make hotel reservations early, as the seminar room block will fill up quickly.

    Start Signature

    Dated: June 19, 2009.

    Jeffrey Shuren,

    Associate Commissioner for Policy and Planning.

    End Signature End Supplemental Information

    [FR Doc. E9-14907 Filed 6-23-09; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Comments Received:
0 Comments
Published:
06/24/2009
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice of public seminar.
Document Number:
E9-14907
Dates:
For the dates of the public seminars, see table 1 in the SUPPLEMENTARY INFORMATION section of this document.
Pages:
30099-30100 (2 pages)
Docket Numbers:
Docket No. FDA-2009-N-0664
PDF File:
e9-14907.pdf